Patent Assignment
Reel/Frame 053672/0069
Merger and Change of Name
Recorded: 2020-09-02
Pages: 5
Assignors
LUMENA PHARMACEUTICALS LLC
Executed: 2020-06-26
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2020-06-26
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
Application:
16/696,196 →
Publication:
US 2020/0207797
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 2, 2020
From: GEDULIN, BRONISLAVA; GREY, MICHAEL; O'DONNELL, NIALL
To: LUMENA PHARMACEUTICALS, INC.
Reel/Frame 053672/0476 →
Change of Name
Sep 2, 2020
From: LUMENA PHARMACEUTICALS, INC.
To: LUMENA PHARMACEUTICALS LLC
Reel/Frame 053672/0636 →
Security Interest
Dec 9, 2020
From: MIRUM PHARMACEUTICALS, INC.
To: MULHOLLAND SA LLC
Reel/Frame 054598/0910 →
Release of Security Interest
Apr 20, 2023
From: MULHOLLAND SA LLC
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 063383/0795 →